Pulmonary Vascular Disease
Questions discussed in this category
Provoked or unprovoked VTE: Do you use D-Dimer (or even repeat imaging to reassess residual clot) in any capacity to guide anticoagulation duration? E...
The patient takes frequent flights for their job, with no prior history of VTE, and has already been taking measures for prevention including frequent...
Is there a difference in monitoring frequency for legacy drugs like bosentan vs newer agents (macitentan, ambrisentan)?
If there are a low-risk patients who can be monitored, how would you do so?
If unprovoked, would you consider stopping anticoagulation?
9286217751688214183134778198
Papers discussed in this category
AJR Am J Roentgenol,
Blood, 2020 Jan 30
Cochrane Database Syst Rev, 2021 Mar 26
Blood Adv,
CMAJ,
N Engl J Med, 2021 Jan 13
Journal of general internal medicine, 2007-01
Blood advances, 2018-11-27
Blood advances, 2023 Nov 28